C.M. Bidwell & Associates’s St Jude Medical STJ Stock Holding History

C.M. Bidwell & Associates’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-108,195	Closed	-$6.68M	–	347
2015 Q4	$6.68M	Buy	108,195 +53,360	+97%	+$3.37M	1.59%	15
2015 Q3	$3.46M	Buy	54,835 +3,590	+7%	+$256K	0.85%	59
2015 Q2	$3.74M	Sell	51,245 -15	-0%	-$1.08K	0.84%	61
2015 Q1	$3.35M	Buy	+51,260	New	+$3.41M	0.74%	69
2014 Q3	–	Sell	-1,140	Closed	-$79K	–	321
2014 Q2	$79K	Sell	1,140 -2,880	-72%	-$187K	0.02%	198
2014 Q1	$263K	Sell	4,020 -380	-9%	-$24.7K	0.06%	122
2013 Q4	$273K	Buy	4,400 +800	+22%	+$46.3K	0.07%	119
2013 Q3	$193K	Buy	+3,600	New	+$185K	0.05%	160

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

C.M. Bidwell & Associates's STJ Position: Q1 2016 in Review

C.M. Bidwell & Associates sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 108,195 shares — an estimated $6.68M sold.

C.M. Bidwell & Associates first reported a position in STJ in Q3 2013 and held it in 8 quarters. The position peaked at $6.68M in Q4 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

C.M. Bidwell & Associates reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
C.M. Bidwell & Associates sold 108,195 St Jude Medical shares in Q1 2016, an estimated $6.68M.
C.M. Bidwell & Associates first reported a position in St Jude Medical in Q3 2013 and held it in 8 quarters.
C.M. Bidwell & Associates's St Jude Medical position peaked at $6.68M in Q4 2015.
570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2016, filed 11 May 2016.